ACC.26 advanced registration ends Feb. 12 – register now!

Kevin Michael Alexander, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Arbor Biotechnologies(SIGNIFICANT), Attralus(MODEST), Prothena(MODEST) RESEARCH/RESEARCH GRANTS: Bridgebio(NONE)

View Full Disclosure